Clinical factors influencing response to intravenous immunoglobulin treatment in cases of refractory pyoderma gangrenosum

被引：0
|
作者：
Haag, C. [1 ]
Keller, J. [1 ]
Ortega-Loayza, A. [1 ]
Fett, N. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 05期
关键词：
D O I：
10.1016/j.jid.2018.03.368
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
362
引用
收藏
页码：S61 / S61
页数：1
相关论文
共 50 条
  • [41] A retrospective review of 23 cases of pyoderma gangrenosum: Effects of comorbid conditions on treatment response
    Nymeyer, H.
    Wong, H. K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S64 - S64
  • [42] Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 PatientsIntravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective AnalysisM. Ronicke et al.
    Moritz Ronicke
    Lukas Sollfrank
    Martin V. Vitus
    Lukas J. Walter
    Manuel Krieter
    Maurice Moelleken
    Joachim Dissemond
    Erwin Schultz
    Felix Lauffer
    Peter von den Driesch
    Cornelia Erfurt-Berge
    American Journal of Clinical Dermatology, 2025, 26 (1) : 139 - 146
  • [43] Intravenous immunoglobulin is effective as a sole immunomodulatory agent in pyoderma gangrenosum unresponsive to systemic corticosteroids
    Suchak, R.
    Macedo, C.
    Glover, M.
    Lawlor, F.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (02) : 205 - 207
  • [44] Intravenous immunoglobulin is effective as a sole inummomodulatory agent in pyoderma gangrenosum unresponsive to systemic corticosteroids
    Suchak, R
    Lawlor, F
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB241 - AB241
  • [45] Pyoderma gangrenosum in the head location: a clinical study of three cases
    Baranska-Rybak, Wioletta
    Komorowska, Olivia
    Szczerkowska-Dobosz, Aneta
    Nowicki, Roman
    Roszkiewicz, Jadwiga
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2011, 28 (05): : 412 - 417
  • [46] Efficacy and Factors Associated with Treatment Response of Intravenous Immunoglobulin in Inpatients with Refractory Inflammatory Bowel Diseases
    Horton, Nicholas
    Kochhar, Gursimran
    Patel, Kajal
    Lopez, Rocio
    Shen, Bo
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (07) : 1080 - 1087
  • [47] Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum
    Seishima, M
    Fujisawa, T
    Yamanaka, S
    Aoki, T
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB14 - AB14
  • [48] Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum
    Seishima, Mariko
    Mizutani, Yoko
    Shibuya, Yoshinao
    Nagasawa, Chikako
    Aoki, Takahiko
    THERAPEUTIC APHERESIS AND DIALYSIS, 2007, 11 (03) : 177 - 182
  • [49] Refractory and infected pyoderma gangrenosum in a patient with ulcerative colitis:: Response to infliximab
    Martin, F. De la Morena L.
    Gisbert, J. P.
    Goiriz, J. Fernandez Herrera R.
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (04) : 509 - 510
  • [50] Clinical patterns and treatment of pyoderma gangrenosum in a French department
    Anuset, D.
    Reguiai, Z.
    Perceau, G.
    Colomb, M.
    Durlach, A.
    Bernard, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2016, 143 (02): : 108 - 117
12345